Intersect ENT Inc (XENT):企業の財務・戦略的SWOT分析

◆英語タイトル:Intersect ENT Inc (XENT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14478
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Intersect develops sinus drug delivery technology. Intersect’s products are used in chronic sinusitis treatment such as facial pain or pressure, nasal congestion and obstruction, loss of smell and taste, headache, discolored nasal discharge, loss of sleep and fatigue and depression. The company also develops propel dissolvable sinus drug delivery stent to help open the sinuses. It markets its products in the US and abroad. Intersect is headquartered in Menlo Park, California, the US.

Intersect ENT Inc Key Recent Developments

Feb 25,2019: Intersect ENT announces fourth quarter and full year 2018 results
Jan 07,2019: Intersect ENT Reports Preliminary Fourth Quarter and Full Year 2018 Revenue
Nov 05,2018: Intersect ENT reports third quarter 2018 results
Oct 29,2018: Intersect ENT announces executive team appointments

This comprehensive SWOT profile of Intersect ENT Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intersect ENT Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Intersect ENT Inc – Key Information
Intersect ENT Inc – Overview
Intersect ENT Inc – Key Employees
Intersect ENT Inc – Key Employee Biographies
Intersect ENT Inc – Key Operational Heads
Intersect ENT Inc – Major Products and Services
Intersect ENT Inc – History
Intersect ENT Inc – Company Statement
Intersect ENT Inc – Locations And Subsidiaries
Intersect ENT Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Intersect ENT Inc – Business Description
Intersect ENT Inc – Corporate Strategy
Intersect ENT Inc – SWOT Analysis
SWOT Analysis – Overview
Intersect ENT Inc – Strengths
Intersect ENT Inc – Weaknesses
Intersect ENT Inc – Opportunities
Intersect ENT Inc – Threats
Intersect ENT Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Intersect ENT Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Intersect ENT Inc, Key Information
Intersect ENT Inc, Key Ratios
Intersect ENT Inc, Share Data
Intersect ENT Inc, Major Products and Services
Intersect ENT Inc, History
Intersect ENT Inc, Key Employees
Intersect ENT Inc, Key Employee Biographies
Intersect ENT Inc, Key Operational Heads
Intersect ENT Inc, Other Locations
Intersect ENT Inc, Subsidiaries
Intersect ENT Inc, Key Manufacturing facilities
Intersect ENT Inc, Key Competitors
Intersect ENT Inc, SWOT Analysis
Intersect ENT Inc, Ratios based on current share price
Intersect ENT Inc, Annual Ratios
Intersect ENT Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Intersect ENT Inc, Performance Chart
Intersect ENT Inc, Ratio Charts

★海外企業調査レポート[Intersect ENT Inc (XENT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ironwood Pharmaceuticals Inc (IRWD):企業の財務・戦略的SWOT分析
    Ironwood Pharmaceuticals Inc (IRWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • FirstGroup plc (FGP):企業の財務・戦略的SWOT分析
    FirstGroup plc (FGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Puracap Pharmaceutical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Puracap Pharmaceutical LLC (PuraCap) is a drug development company that offers prescription generics and OTC products. The company provides over the counter soft gels and oral solid dosage healthcare products for upper respiratory, pain relief, cough and cold, sleep aid, gastrointestinal, an …
  • Royal College of Surgeons Ireland-製薬・医療分野:企業M&A・提携分析
    Summary Royal College of Surgeons Ireland (RCSI) is a not-for-profit organization that offers medical education and training in healthcare professions at undergraduate and postgraduate levels. The organization offers undergraduate courses in nursing, postgraduate research, postgraduate taught, leade …
  • Andersen Construction Co:企業の戦略的SWOT分析
    Andersen Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Navidea Biopharmaceuticals Inc (NAVB):医療機器:M&Aディール及び事業提携情報
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline prod …
  • JFE Holdings Inc (5411):企業の財務・戦略的SWOT分析
    JFE Holdings Inc (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Orthosera GmbH (OrthoSera), formerly Lacerta Technologies GmbH is a regenerative medicine company that develops blood serum for human diseases. The company offers Albumin, a bone protein used in treatment of patients suffering from bone loss. It develops technologies for identification of ne …
  • Societe Anonyme Belge de Constructions Aeronautiques:企業の戦略・SWOT・財務分析
    Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report Summary Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • National Industrialization Co (2060):企業の財務・戦略的SWOT分析
    National Industrialization Co (2060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tillotts Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Tillotts Pharma AG (Tillotts), a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products are used for the treatment of var …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sangui BioTech International Inc (SGBI):企業の財務・戦略的SWOT分析
    Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • SOLX Inc-医療機器分野:企業M&A・提携分析
    Summary Solx Inc (SOLX) is a medical device company that develops therapeutic products. The company provides glaucoma surgery devices and treatments for glaucoma therapy. Its SOLX gold shunt is a minimally invasive device, which is used in surgical treatment of glaucoma. SOLX’s product is a gold imp …
  • Allianz Seguros S.A.:企業の戦略・SWOT・財務情報
    Allianz Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Allianz Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lam Research Corporation (LRCX):企業の財務・戦略的SWOT分析
    Lam Research Corporation (LRCX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Cobalt International Energy, Inc. (CIE)-石油・ガス分野:企業M&A・提携分析
    Summary Cobalt International Energy, Inc. (Cobalt) is an independent upstream oil and gas company. The company explores for, develops and produces oil and gas from its assets. It has assets in deepwater US Gulf of Mexico and offshore Angola and Gabon in West Africa. The company’s Gulf of Mexico asse …
  • Crown Point Energy Inc (CWV):企業の財務・戦略的SWOT分析
    Summary Crown Point Energy Inc (Crown Point), formerly Crown Point Ventures is an oil and gas company that offers oil and gas development and exploration services. The company acquires and produces crude oil and natural gas deposits. It holds interests in Cerro de Los Leones exploration concessions …
  • Misen Energy AB (MISE):企業の財務・戦略的SWOT分析
    Summary Misen Energy AB (Misen), formerly Svenska Capital Oil AB is an oil and gas company that provides pipeline services. The company offers production of gas and oil fields by implementation of large-scale investment programs and introduction of modern western knowhow and technology. It offers de …
  • Aleris Corporation:企業のM&A・事業提携・投資動向
    Aleris Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aleris Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆